source
- Nvidia-backed Iambic Therapeutics raises $150M in IPO, begins trading ThursdayIambic Therapeutics, a biotech focused on using artificial intelligence to develop cancer treatments, announced the completion of its initial public offering. The company sold 9.38 million shares…
- Compass Pathways CEO says company will proceed cautiously as it readies psychedelic therapy for FDA reviewCompass Pathways chief executive Kabir Nath told reporters at the STAT Summit that the company will "go slow before we go fast," emphasizing that early negative experiences could hurt the emerging…